Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.
For the
three
months ended in Mar. 2026,
Scientific Industries paid$0.00 Mil more to buy back shares than it received from issuing new shares.
It received$0.00 Mil from issuing more debt.
It paid$0.00 Mil more to buy back preferred shares than it received from issuing preferred shares.
It received$0.00 Mil from paying cash dividends to shareholders.
It received$0.00 Mil on other financial activities.
In all, Scientific Industriesspent$0.00 Mil on financial activities for the
three
months ended in Mar. 2026.
Scientific Industries (OTCPK:SCND) Cash Flow from Financing Explanation
Cash from financing contains six items:
1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.
Scientific Industries's issuance of stock for the
three
months ended in Mar. 2026 was $0.00 Mil.
2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.
Scientific Industries's repurchase of stock for the
three
months ended in Mar. 2026 was $0.00 Mil.
3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.
Scientific Industries's net issuance of debt for the
three
months ended in Mar. 2026 was $0.00 Mil.
Scientific Industries received$0.00 Mil from issuing more debt.
4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.
Scientific Industries's net issuance of preferred for the
three
months ended in Mar. 2026 was $0.00 Mil.
Scientific Industries paid$0.00 Mil more to buy back preferred shares than it received from issuing preferred shares.
5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.
Scientific Industries's cash flow for dividends for the
three
months ended in Mar. 2026 was $0.00 Mil.
Scientific Industries received$0.00 Mil from paying cash dividends to shareholders.
6. Other Financing:
Money spent or earned by company from other financial activities.
Scientific Industries's other financing for the
three
months ended in Mar. 2026 was $0.00 Mil.
Scientific Industries received$0.00 Mil on other financial activities.
Scientific Industries Cash Flow from Financing Related Terms
Scientific Industries Cash Flow from Financing Historical Data
* Premium members only.
The historical data trend for Scientific Industries's Cash Flow from Financing can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Scientific Industries Cash Flow from Financing Chart
Scientific Industries Cash Flow from Financing Calculation
This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.
Scientific Industries's Cash from Financing for the fiscal year that ended in Dec. 2025 is calculated as:
Cash Flow from Financing for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.95 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Cash Flow from Financing of $1.95 Mil mean?
Scientific Industries (SCND) has a Cash Flow from Financing of $1.95 Mil as of Mar. 2026. Cash Flow from Financing is the amount of cash earned or paid from financing operations. View historical data for Scientific Industries and its competitors.
Is Scientific Industries' Cash Flow from Financing too high?
Scientific Industries' current Cash Flow from Financing is $1.95 Mil. Overall, Scientific Industries has a GF Score™ of 25/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Scientific Industries' Cash Flow from Financing compare to LCTC and QURT?
Scientific Industries' Cash Flow from Financing of $1.95 Mil can be compared against companies in the Hardware industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow from Financing for a Hardware company?
A good Cash Flow from Financing depends on the Hardware industry context. However, Cash Flow from Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow from Financing mean?
A high Cash Flow from Financing can signal that a stock is expensive relative to its fundamentals. Cash Flow from Financing is the amount of cash earned or paid from financing operations. View historical data for Scientific Industries and its competitors. Scientific Industries's current Cash Flow from Financing is $1.95 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scientific Industries stock overvalued right now?
Based on GuruFocus' analysis, Scientific Industries (SCND) is currently considered Fairly Valued. The stock's GF Value™ is $0.74, compared to a current price of $0.70 — trading 5.4% below its estimated fair value. The current Cash Flow from Financing is $1.95 Mil. Scientific Industries' overall GF Score™ is 25/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow from Financing calculated?
Cash Flow from Financing is calculated from a company's financial statements. For Scientific Industries (SCND), the current Cash Flow from Financing is $1.95 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Scientific Industries (SCND) Overvalued in 2026?
Based on GuruFocus' analysis, Scientific Industries stock appears to be undervalued.
The current stock price of $0.70 is trading 5.4% below its estimated GF Value™ of $0.74.
GuruFocus considers Scientific Industries to be Fairly Valued.
Key valuation signals for SCND:
Cash Flow from Financing: $1.95 Mil
GF Value™: $0.74 vs. price of $0.70 (5.4% below fair value)
No single metric tells the full story. See the SCND stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Scientific Industries Inc is engaged in the design, manufacture, and marketing of benchtop laboratory equipment. Its products are used for research purposes by universities, pharmaceutical companies, pharmacies, national laboratories, medical device manufacturers, petrochemical companies, and other industries performing laboratory-scale research. The company's operating segment includes Benchtop Laboratory Equipment, Bioprocessing Systems and Corporate. It generates maximum revenue from the Benchtop Laboratory Equipment segment. The company offers equipment products such as mixers, shakers, stirrers, refrigerated incubators, pharmacy balances and scales, force gauges, catalyst instruments, reactor systems, and high throughput systems.
25GF Score
Get the complete analysis for SCND
Cash Flow from Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SCND has been successfully added to your 
